NB 001 may reduce symptom duration in patients with herpes labialis

Source: Inpharma, Volume 1, Number 1498, 2005-07-30 , pp. 7-7(1)

Publisher: Adis International

Keywords: Drug-delivery-systems; Herpes-labialis, treatment; NB-001, therapeutic use; Research-and-development; Trial-result-clinical

Document Type: Short communication

Publication date: 2005-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers